20Lighter Announces New Patent Issued for Reduction of Hypertension
This patent and an additional continuation application expand 20Lighter’s portfolio and emphasize therapeutic value for patients with cardiovascular disease. LITTLE ROCK, AR, UNITED STATES, April 12, 2022 /EINPresswire.com/ -- 20Lighter, LLC, a private …